Leah M. Wilson et al.: Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial. In: Diabetes Care. Band43, Nr.11, 1. November 2020, S.2721–2729, doi:10.2337/dc19-2267.
Mikkel Bring Christensen: Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. In: Danish Medical Journal. Band63, Nr.4, April 2016, PMID 27034187.
pharmavista.net
Schweizerisches Toxikologisches Informationszentrum, Antidot-Monographie für Glucagon; pharmavista.net (PDF; 39 kB)